The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
34
No.
46
December 19, 2008
- Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.
- Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.
- Cancer Groups Propose Six Characteristics Of Next FDA Head.
- NCCS Urges FDA To Finalize Regulations On Expanded Access.
- NCI Advisors Approve Continuation Of Cancer Genome Atlas Network.
CCL
Vol.
31
No.
12
December 26, 2008
- Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds
- Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence
- Age Doesn’t Affect Survival After Bone Marrow Transplant
- Lenalidomide Found Effective For Lymphoma In Phase II Trial
- Intensive Chemo Equivalent To Transplant For MCL
- Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant
- Arzerra Promising For Heavily Pre-Treated CLL Patients
- Dismissed Leukemia Drug Helps CLL, Clinical Trials Find
- PDX Shows 27% Response In T-Cell Lymphoma In Study
- Second-Generation CML Drugs Show Promise For Frontline
- Gleevec To Prevent Recurrence Of Gastrointestinal Cancer
- NCI Cooperative Group, Cancer Center Trials Listed